GlassScriptPhysician profile
Rebecca Heath
NPI 1851814180
$2,182.07
in general payments reported to CMS, 2019-2025
15 companies · $402 in 2025
The $402 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $457 · 2020: $12.26 · 2022: $131 · 2023: $598 · 2024: $582 · 2025: $402.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,582.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,581.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $853.94 | 2019-2025 | Argos, Clareon, Clareon Panoptix Pro |
| Bausch & Lomb Americas INC. | $221.58 | 2024 | Miebo, Xiidra |
| Glaukos Corporation | $158.15 | 2019-2023 | Istent Infinite Trabecular Micro-Bypass System Model Is3 |
| Tarsus Pharmaceuticals, INC. | $136.04 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $124.64 | 2023 | Tyrvaya |
| Abbvie INC. | $121.97 | 2023-2024 | |
| Shire North American Group INC | $121.88 | 2019 | |
| Dompe US, INC. | $91.50 | 2025 | Oxervate |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $88.09 | 2019 | |
| Mallinckrodt Enterprises LLC | $79.53 | 2019 | |
| Sun Pharmaceutical Industries INC. | $58.46 | 2019-2025 | |
| Allergan, INC. | $56.21 | 2019-2020 | |
| Kala Pharmaceuticals, INC. | $33.96 | 2019 | |
| New World Medical,INC. | $18.80 | 2019 | |
| Aerie Pharmaceuticals, INC. | $17.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rebecca Heath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.